Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database

BACKGROUND: Pneumocystis jiroveci pneumonia (PCP) prophylaxis is recommended for patients with CD4 counts of less than 200 cells/mm(3). This study examines the proportion of patients in the TREAT Asia HIV Observational Database (TAHOD) receiving PCP prophylaxis, and its effect on PCP and mortality....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lim, Poh-Lian, Zhou, Jialun, Ditangco, Rossana A, Law, Matthew G, Sirisanthana, Thira, Kumarasamy, Nagalingeswaran, Chen, Yi-Ming A, Phanuphak, Praphan, Lee, Christopher KC, Saphonn, Vonthanak, Oka, Shinichi, Zhang, Fujie, Choi, Jun Y, Pujari, Sanjay, Kamarulzaman, Adeeba, Li, Patrick CK, Merati, Tuti P, Yunihastuti, Evy, Messerschmidt, Liesl, Sungkanuparph, Somnuek
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The International AIDS Society 2012
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3354658/
https://ncbi.nlm.nih.gov/pubmed/22281054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-2652-15-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller